A randomized controlled clinical trial of topical insulin-like growth factor-1 therapy for sudden deafness refractory to systemic corticosteroid treatment.

A randomized controlled clinical trial of topical insulin-like growth factor-1 therapy for sudden deafness refractory to systemic corticosteroid treatment.

Item
http://www.wikidata.org/entity/Q34537290
Sphingosine 1-phosphate signaling pathway in inner ear biology. New therapeutic strategies for hearing loss?Towards Clinical Application of Neurotrophic Factors to the Auditory Nerve; Assessment of Safety and Efficacy by a Systematic Review of Neurotrophic Treatments in Humans.Nanoparticle mediated drug delivery of rolipram to tyrosine kinase B positive cells in the inner ear with targeting peptides and agonistic antibodies.Aminophylline restores glucocorticoid sensitivity in a guinea pig model of sudden sensorineural hearing loss induced by lipopolysaccharide.Insulin-like Growth Factor 1 in relation to future hearing impairment: findings from the English Longitudinal Study of Ageing.Resolution of Cochlear Inflammation: Novel Target for Preventing or Ameliorating Drug-, Noise- and Age-related Hearing Loss.Targeting cholesterol homeostasis to fight hearing loss: a new perspective.How controlled release technology can aid gene delivery.An update on drug design strategies to prevent acquired sensorineural hearing loss.Safety of Repeated-Dose Intratympanic Injections with AM-101 in Acute Inner Ear Tinnitus.Otoprotective effects of mouse nerve growth factor in DBA/2J mice with early-onset progressive hearing loss.The Role of Insulin-Like Growth Factor 1 in the Progression of Age-Related Hearing Loss.Reduction of Proliferating Olfactory Cells and Low Expression of Extracellular Matrix Genes Are Hallmarks of the Aged Olfactory Mucosa.Regeneration of Cochlear Hair Cells and Hearing Recovery through Hes1 Modulation with siRNA Nanoparticles in Adult Guinea Pigs
P2860

A randomized controlled clinical trial of topical insulin-like growth factor-1 therapy for sudden deafness refractory to systemic corticosteroid treatment.

Item
http://www.wikidata.org/entity/Q34537290
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A randomized controlled clinic ...... emic corticosteroid treatment.
@ast
A randomized controlled clinic ...... emic corticosteroid treatment.
@en
A randomized controlled clinic ...... emic corticosteroid treatment.
@nl
type
label
A randomized controlled clinic ...... emic corticosteroid treatment.
@ast
A randomized controlled clinic ...... emic corticosteroid treatment.
@en
A randomized controlled clinic ...... emic corticosteroid treatment.
@nl
prefLabel
A randomized controlled clinic ...... emic corticosteroid treatment.
@ast
A randomized controlled clinic ...... emic corticosteroid treatment.
@en
A randomized controlled clinic ...... emic corticosteroid treatment.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P478
P50
P577
P6179
P698
P921
P932
P356
P1433
P1476
A randomized controlled clinic ...... temic corticosteroid treatment
@en
P2093
P2860
P2888
P304
P31
P356
P407
P478
P50
P577
P6179
P698
P921
P932